×
About 688 results

ALLMedicine™ Alopecia Areata Center

Research & Reviews  244 results

Resident human dermal γδT-cells operate as stress-sentinels: Lessons from the hair foll...
https://doi.org/10.1016/j.jaut.2021.102711
Journal of Autoimmunity; Uchida Y, Gherardini J et. al.

Sep 4th, 2021 - Murine γδT-cells have stress-surveillance functions and are implicated in autoimmunity. Yet, whether human γδT-cells are also stress sentinels and directly promote autoimmune responses in the skin is unknown. Using a novel (mini-)organ assay, we t...

Development of the Alopecia Areata Scale for Clinical Use: Results of an Academic-Indus...
https://doi.org/10.1016/j.jaad.2021.08.043
Journal of the American Academy of Dermatology; King BA, Mesinkovska NA et. al.

Sep 3rd, 2021 - The current classification for Alopecia Areata (AA) does not provide a consistent assessment of disease severity. To develop an AA severity scale based on expert experience. A Modified Delphi process was utilized. An advisory group of 22 US-based ...

Phase 2a randomized clinical trial of dupilumab (anti-IL-4Rα) for alopecia areata patie...
https://doi.org/10.1111/all.15071
Allergy Guttman-Yassky E, Renert-Yuval Y et. al.

Aug 31st, 2021 - Treatments for alopecia areata (AA) patients with extensive scalp hair loss are limited, and recent evidence supports a role for type 2 T-cell (Th2)-immune response in AA. Dupilumab, a monoclonal antibody inhibiting Th2 signaling, approved for typ...

Alopecia areata: A psychodermatological perspective.
https://doi.org/10.1111/jocd.14416
Journal of Cosmetic Dermatology; Torales J, Castaldelli-Maia JM et. al.

Aug 28th, 2021 - Alopecia Areata (AA) is an autoimmune dermatological disease that could be influenced by psychological factors as part of the pathophysiology of the illness. This review article aims to report on psychodermatological and psychopathological aspects...

Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management.
https://doi.org/10.1007/s12016-021-08883-0 10.1016/j.jaad.2020.06.047 10.1016/j.jaad.2019.08.032 10.1016/j.jaad.2017.04.1141 10.1007/s40265-020-01293-0 10.1111/exd.14073 10.1016/j.jaut.2018.12.001 10.1111/bjd.16808 10.1016/j.jaci.2019.08.035 10.1111/jdv.15489 10.1016/j.jaci.2017.10.028 10.1016/j.jaad.2017.04.1142 10.1016/j.jaad.2005.12.007 10.1016/s0190-9622(98)70499-2 10.1016/j.jaad.2009.02.006 10.1086/511442 10.1038/nature09114 10.1038/JID.2015.402 10.1038/jid.2012.129 10.1016/j.ebiom.2020.102810 10.1016/j.jisp.2020.04.003 10.1111/exd.13123 10.1111/exd.13986 10.1111/exd.14155 10.1056/NEJMra1103442 10.1016/j.autrev.2016.03.008 10.1111/j.1365-2133.2006.07377.x 10.1111/j.0022-202X.2004.23580.x 10.1038/nm.3645 10.1038/nm.3685 10.1016/j.jaut.2018.04.001 10.1111/jdv.14775 10.1001/jamadermatol.2014.504 10.1159/000350933 10.1111/1346-8138.12978 10.1111/jdv.12932 10.1016/j.alit.2019.07.009 10.1371/journal.pone.0094260 10.1007/s00403-015-1539-1 10.1111/exd.14129 10.1001/jamadermatol.2014.62 10.1016/j.jid.2016.04.004 10.1046/j.0022-202x.2001.01583.x 10.1111/ced.12556 10.5152/balkanmedj.2016.16190 10.1111/ijd.14753 10.1001/jamadermatol.2014.3324 10.1016/j.jaad.2009.04.031 10.4103/0378-6323.102361 10.1111/ced.12471 10.1111/exd.14027 10.1016/j.jaad.2020.06.1026 10.1016/j.jdermsci.2010.03.009 10.1038/nature18848 10.1034/j.1600-0625.2003.120104.x 10.1111/jdv.15885 10.1111/bjd.19461 10.1371/journal.pone.0215206 10.1038/gene.2017.4 10.1016/j.molmed.2011.07.005 10.3389/fimmu.2019.00856 10.1111/j.1365-2133.2011.10646.x 10.1016/j.jid.2017.09.046 10.1002/jcb.28700 10.1016/j.jaad.2018.12.047 10.1007/s12016-017-8620-9 10.1016/j.jaad.2009.05.001 10.5826/dpc.0904a05 10.1159/000249182 10.1016/j.jaad.2008.07.062 10.1016/j.clindermatol.2013.06.003 10.1111/ijd.13866 10.1111/1346-8138.14283 10.1016/j.jaad.2012.02.013 10.4103/0019-5154.84768 10.1159/000490459 10.1016/j.jaad.2011.02.017 10.1016/j.det.2012.08.001 10.1111/1346-8138.12591 10.1111/j.1365-2133.2012.10955.x 10.1111/jdv.15582 10.1016/j.jaad.2006.05.008 10.1111/ajd.12941 10.1159/000442816 10.1016/j.jaad.2018.08.059 10.1111/bjd.18883 10.1111/bjd.19024 10.1007/s40257-020-00545-9 10.1016/j.jaad.2015.04.049 10.1016/j.jaad.2019.11.066 10.1097/00055735-200012000-00016 10.1016/j.jaad.2004.10.873 10.1016/j.jaad.2015.12.026 10.2147/dddt.S214907 10.1111/jdv.15545 10.1111/ijd.14933 10.1001/jamadermatol.2018.2312 10.1007/s13555-018-0226-5 10.1111/exd.13758 10.1016/j.jaad.2019.10.043 10.1016/j.jaad.2019.04.053 10.1016/j.jaad.2015.12.055 10.1111/1346-8138.13933 10.1038/nrrheum.2015.167 10.1016/j.immuni.2012.03.014 10.1016/j.jaad.2016.12.005 10.1038/ncomms6966 10.1172/jci.insight.89776 10.1016/j.jid.2018.01.032 10.1016/j.jaad.2016.09.007 10.1016/j.jaad.2016.09.006 10.1016/j.jaad.2018.08.041 10.1016/j.jaad.2018.12.041 10.1172/jci.insight.89790 10.1016/j.ebiom.2015.02.015 10.1016/j.jdcr.2019.07.005 10.1080/17512433.2020.1702878 10.1007/s40744-020-00258-9 10.1126/sciadv.1500973 10.1111/jdv.15489 10.3389/fimmu.2019.02847 10.1177/120347541201600407 10.1016/j.jaad.2005.03.039 10.1001/archdermatol.2009.264 10.1016/j.jaad.2007.10.645 10.1016/j.jaci.2015.06.032 10.1007/s00403-018-1853-5 10.1016/j.jaad.2020.08.051 10.1111/bjd.18976 10.1016/j.jdcr.2020.10.010 10.1111/bjd.16711 10.1111/jdv.16493 10.1016/j.jdcr.2017.11.020 10.3315/jdcr.2010.1041 10.1684/ejd.2013.2221 10.1016/j.jaci.2015.11.001 10.1111/pde.13699 10.1684/ejd.2020.3866 10.1016/j.jdcr.2019.10.012 10.1159/000499030 10.1007/s40265-014-0218-4 10.1016/j.jdermsci.2014.11.009 10.1080/09546634.2019.1616046 10.1684/ejd.2019.3576 10.1007/s00403-018-1876-y 10.1016/j.jaad.2017.11.056 10.1684/ejd.2020.3749 10.1080/09546634.2019.1589641 10.1016/j.jaad.2017.05.034 10.1038/nrd1989 10.1016/j.jaad.2020.09.091 10.1136/annrheumdis-2016-210724 10.1016/j.jisp.2020.05.002 10.1111/j.1524-4725.2012.02394.x 10.1111/bjd.12397 10.1111/jocd.12858 10.1016/j.jdcr.2015.07.004 10.1111/dth.12989 10.1056/NEJMoa1105143 10.1038/nrd.2018.148 10.1016/j.jid.2020.08.015 10.1016/j.jisp.2017.10.013 10.1016/j.jaad.2020.03.102 10.1016/j.jaad.2014.11.006 10.1159/000468991 10.5021/ad.2017.29.6.755 10.1016/j.jaad.2015.09.071 10.1016/j.jaad.2019.04.047 10.1111/j.1346-8138.2007.00401.x 10.1111/j.1346-8138.2009.00647.x 10.1046/j.1365-2222.2003.01701.x 10.1016/s0002-9394(14)70870-0 10.1111/j.1365-2133.2010.09685.x 10.1111/j.1468-3083.2009.03543.x 10.1016/j.jaad.2009.01.027 10.1016/j.jaad.2008.08.029 10.1159/000371416 10.1080/09546634.2017.1330527 10.1111/pde.12920 10.1016/j.jaad.2017.06.027 10.1159/000494613 10.1016/j.jaad.2017.03.024 10.1016/j.jdcr.2019.07.005 10.1002/acr.24007 10.1002/art.41316
Clinical Reviews in Allergy & Immunology; Zhou C, Li X et. al.

Aug 18th, 2021 - Alopecia areata (AA) is a common chronic tissue-specific autoimmune disease, resulting in hair loss, that affects up to 2% of the general population. The exact pathobiology of AA has still remained elusive, while the common theory is the collapse ...

see more →

News  31 results

Pediatric Alopecia Areata in the US Has Increased Twofold Since 2009, Study Finds
https://www.medscape.com/viewarticle/954901

Jul 16th, 2021 - The prevalence of pediatric alopecia areata (AA) in the United States has increased twofold over the past decade and it disproportionately affects females and Hispanic children, according to results from the largest study to date on the topic. "Al...

Alopecia Patients May Be at Increased Risk of Heart Attack
https://www.medscape.com/viewarticle/930946

May 22nd, 2020 - NEW YORK (Reuters Health) - Patients with alopecia areata (AA) appear to be at heightened risk of acute myocardial infarction (AMI), according to a large population-based study from South Korea. "Our findings possibly imply that AA is not an autoi...

Alopecia Patients May Be at Increased Risk of Heart Attack
https://www.staging.medscape.com/viewarticle/930946

May 22nd, 2020 - NEW YORK (Reuters Health) - Patients with alopecia areata (AA) appear to be at heightened risk of acute myocardial infarction (AMI), according to a large population-based study from South Korea. "Our findings possibly imply that AA is not an autoi...

Dermatology therapies evolve as disease knowledge and investment grow
https://www.mdedge.com/dermatology/article/219314/medical-dermatology/dermatology-therapies-evolve-disease-knowledge-and/page/0/2?channel=27980

Mar 19th, 2020 - Spillover to other diseases JAK inhibitors – some in oral and some in topical form – are showing efficacy in ongoing research for alopecia areata (AA) and vitiligo as well, Dr. Blauvelt said.

Pitting of fingernails
https://www.mdedge.com/familymedicine/article/215178/dermatology/pitting-fingernails?channel=203
MDedge Family Medicine;

Jan 23rd, 2020 - Given the constellation of non-scarring alopecia on the patient’s posterior scalp (with no scale, papules, or plaques), the physician diagnosed alopecia areata (AA) with associated nail pitting in this patient. Although a scalp biopsy could have c.

see more →